FDA escalates crackdown on pharmaceutical advertising with new warning letters
TL;DR
The FDA has issued around 100 warning letters to pharma and biotech companies for misleading direct-to-consumer drug advertisements, highlighting specific ads that falsely suggest benefits, downplay risks, or use attention-grabbing visuals that impair understanding, as part of increased enforcement efforts.
- Check out 15 DTC pharma ads that got flagged by FDA Medical Marketing and Media
- FDA Letters Flag Oprah Video, Morgan Freeman Ad in Crackdown Bloomberg.com
- FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz AP News
- FDA warning letters show how it intends to ratchet up pressure over drug ads statnews.com
- U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims Reuters
Want the full story? Read the original reporting
Read on Medical Marketing and Media